Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

1.99
Delayed Data
As of Oct 20
 +0.15 / +8.15%
Today’s Change
1.02
Today|||52-Week Range
2.63
+30.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$226.7M

Company Description

Athersys, Inc. is a biotechnology company, which focuses in the field of regenerative medicine and engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

Contact Information

Athersys, Inc.
3201 Carnegie Avenue
Cleveland Ohio 44115-2634
P:(216) 431-9900
Investor Relations:

Employees

Shareholders

Individual stakeholders8.68%
Other institutional5.73%
Mutual fund holders14.10%

Top Executives

Gil van BokkelenChairman & Chief Executive Officer
William B. J. LehmannPresident, Chief Operating Officer & Secretary
Laura K. CampbellPrincipal Financial & Accounting Officer
John J. HarringtonDirector, Chief Scientific Officer & Executive VP
Manal MorsySenior VP & Head-Global Regulator Affairs